As of 2025-09-18, the Relative Valuation of Vir Biotechnology Inc (VIR) is (63.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.80 USD, the upside of Vir Biotechnology Inc based on Relative Valuation is -1428.5%.
The range of the Relative Valuation is (58.38) - (72.64) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 18.3x | 18.1x |
| Forward P/E multiples | 13.9x - 19.1x | 14.1x |
| Fair Price | (58.38) - (72.64) | (63.77) |
| Upside | -1316.3% - -1613.3% | -1428.5% |
| Date | P/E |
| 2025-09-16 | -1.24 |
| 2025-09-15 | -1.21 |
| 2025-09-12 | -1.26 |
| 2025-09-11 | -1.32 |
| 2025-09-10 | -1.30 |
| 2025-09-09 | -1.32 |
| 2025-09-08 | -1.31 |
| 2025-09-05 | -1.33 |
| 2025-09-04 | -1.30 |
| 2025-09-03 | -1.39 |
| 2025-09-02 | -1.26 |
| 2025-08-29 | -1.25 |
| 2025-08-28 | -1.27 |
| 2025-08-27 | -1.32 |
| 2025-08-26 | -1.12 |
| 2025-08-25 | -1.11 |
| 2025-08-22 | -1.16 |
| 2025-08-21 | -1.11 |
| 2025-08-20 | -1.10 |
| 2025-08-19 | -1.10 |
| 2025-08-18 | -1.13 |
| 2025-08-15 | -1.14 |
| 2025-08-14 | -1.12 |
| 2025-08-13 | -1.15 |
| 2025-08-12 | -1.10 |
| 2025-08-11 | -1.08 |
| 2025-08-08 | -1.09 |
| 2025-08-07 | -1.10 |
| 2025-08-06 | -1.28 |
| 2025-08-05 | -1.29 |
| 2025-08-04 | -1.29 |
| 2025-08-01 | -1.27 |
| 2025-07-31 | -1.28 |
| 2025-07-30 | -1.32 |
| 2025-07-29 | -1.33 |
| 2025-07-28 | -1.38 |
| 2025-07-25 | -1.43 |
| 2025-07-24 | -1.45 |
| 2025-07-23 | -1.48 |
| 2025-07-22 | -1.45 |
| 2025-07-21 | -1.39 |
| 2025-07-18 | -1.37 |
| 2025-07-17 | -1.39 |
| 2025-07-16 | -1.37 |
| 2025-07-15 | -1.34 |
| 2025-07-14 | -1.39 |
| 2025-07-11 | -1.43 |
| 2025-07-10 | -1.50 |
| 2025-07-09 | -1.50 |
| 2025-07-08 | -1.34 |